Published in Women's Health Weekly, July 19th, 2007
"The potential side effects of 2-ME on SCID mice were also investigated. Severe combined immune deficient mice were injected with HEC-1-A cells (1 x 106/mouse) and a 18 day administration of 2-ME was followed after 1 week cell implantation. Tumor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.